Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2024 02:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer

Evox Therapeutics announces the appointment of Dr. Per Lundin as Chief Executive Officer
August 09, 2023 02:00 ET | Source: EVOX THERAPEUTICS LIMITED

Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform

OXFORD, United Kingdom, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced the publication in Nature Communications of...
August 04, 2023 02:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics enters into agreement to advance next generation exosome-delivered AAV gene therapy for the treatment of heart disease

OXFORD, United Kingdom, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced a research collaboration and option agreement with...
June 20, 2023 02:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property

IP bolsters Company’s already dominant and broad position with respect to exosome therapeutics Acquisition is in line with long-term strategy to improve exosome-mediated delivery to enable novel gene...
May 17, 2023 08:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio

OXFORD, United Kingdom, May 17, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted...
May 12, 2023 08:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics Presents Progress Across its DeliverEX® Platform Highlighting Advances in Exosome-Mediated Delivery of Genetic Medicines Including Gene Editing and RNA Therapeutics

OXFORD, United Kingdom, May 12, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, will present data at two upcoming international...
September 07, 2022 07:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio

OXFORD, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted...
May 26, 2022 03:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform with Nine Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting

OXFORD, United Kingdom, May 26, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announced advances in exosome engineering,...
May 24, 2022 08:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics to Present at the 2022 Jefferies Healthcare Conference

OXFORD, United Kingdom, May 24, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, will participate in the 2022 Jefferies Healthcare...
May 19, 2022 08:00 ET | Source: EVOX THERAPEUTICS LIMITED

Evox Therapeutics Announces Data Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting

OXFORD, United Kingdom, May 19, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announced titles of nine abstracts to be presented...

Next Page keyboard_arrow_right